VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway. 2020

Kaicheng Xu, and Haomin Zhao, and Xiaolei Qiu, and Xiwen Liu, and Fucheng Zhao, and Yue Zhao
Department of Anesthesiology, China-Japan Union Hospital, Jilin University, Changchun, Jilin 130033, China.

Vestigial-like 4 (VGLL4) has been found to have multiple functions in tumor development; however, its role in cardiovascular disease is unknown. The aim of this study was to investigate the effect of VGLL4 on the dysfunction and inflammatory response of Ox-LDL-induced human umbilical vein endothelial cells (HUVECs) and its mechanism, so as to provide a new theoretical basis for the diagnosis and treatment of atherosclerosis. In the present study, the protective activity of VGLL4 inhibiting Ox-LDL-induced apoptosis, oxidative stress, inflammation, and injury as well as its molecular mechanisms was examined using human umbilical vein endothelial cells (HUVECs). The results showed that the expression of VGLL4 was decreased with the increase of Ox-LDL concentration in HUVECs. In addition, the functional study found that VGLL4 overexpression alleviated Ox-LDL-induced oxidative stress, inflammation, and dysfunction and inhibited apoptosis. Further research found that VGLL4 regulated Hippo-YAP/TEAD1 signaling pathway, and the Hippo-YAP/TEAD1 signaling pathway was involved in the protective mechanism of VGLL4 on HUVECs. In conclusion, it suggests that VGLL4 protects against oxidized-LDL-induced endothelial cell dysfunction by activating the Hippo-YAP/TEAD1 signaling pathway.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090683 Hippo Signaling Pathway A signaling pathway that plays a key role in regulating tissue and organ growth. The name derives from the protein kinase Hippo (Hpo) found in DROSOPHILA; where mutations of the Hpo gene result in tissue overgrowth and the hippopotamus phenotype. Hippo Pathway,Hippo Signaling,Hippo Signaling Pathways,Signaling Pathway, Hippo
D000091102 YAP-Signaling Proteins Signal transducing adaptor proteins that were initially identified by their association with YES PROTO-ONCOGENE PROTEIN. They are downstream components of the HIPPO-SIGNALING PATHWAY, and act as transcriptional co-activators for TEAD TRANSCRIPTION FACTORS. YAP Intracellular Signaling Proteins,Yes-Associated Proteins,YAP Signaling Proteins,Yes Associated Proteins
D000091262 TEA Domain Transcription Factors A family of transcription factors that share a conserved TEA DNA binding domain. TEA Domain,TEAD Transcription Factors
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2

Related Publications

Kaicheng Xu, and Haomin Zhao, and Xiaolei Qiu, and Xiwen Liu, and Fucheng Zhao, and Yue Zhao
January 2022, Mediators of inflammation,
Kaicheng Xu, and Haomin Zhao, and Xiaolei Qiu, and Xiwen Liu, and Fucheng Zhao, and Yue Zhao
June 2010, Journal of applied physiology (Bethesda, Md. : 1985),
Kaicheng Xu, and Haomin Zhao, and Xiaolei Qiu, and Xiwen Liu, and Fucheng Zhao, and Yue Zhao
January 2013, Evidence-based complementary and alternative medicine : eCAM,
Kaicheng Xu, and Haomin Zhao, and Xiaolei Qiu, and Xiwen Liu, and Fucheng Zhao, and Yue Zhao
January 2022, Cellular and molecular life sciences : CMLS,
Kaicheng Xu, and Haomin Zhao, and Xiaolei Qiu, and Xiwen Liu, and Fucheng Zhao, and Yue Zhao
March 2020, Bioscience reports,
Kaicheng Xu, and Haomin Zhao, and Xiaolei Qiu, and Xiwen Liu, and Fucheng Zhao, and Yue Zhao
September 2019, IUBMB life,
Kaicheng Xu, and Haomin Zhao, and Xiaolei Qiu, and Xiwen Liu, and Fucheng Zhao, and Yue Zhao
July 2020, Bioscience reports,
Kaicheng Xu, and Haomin Zhao, and Xiaolei Qiu, and Xiwen Liu, and Fucheng Zhao, and Yue Zhao
December 2021, Bioengineered,
Kaicheng Xu, and Haomin Zhao, and Xiaolei Qiu, and Xiwen Liu, and Fucheng Zhao, and Yue Zhao
October 2018, IUBMB life,
Kaicheng Xu, and Haomin Zhao, and Xiaolei Qiu, and Xiwen Liu, and Fucheng Zhao, and Yue Zhao
March 2019, Medical science monitor : international medical journal of experimental and clinical research,
Copied contents to your clipboard!